IlluminOss Medical, a privately held, commercial stage medical
device company pioneering the development of minimally invasive,
customized orthopedic implants for the stabilization and treatment of
bone fractures announced that president and CEO Dirk Kuyper will present
at the 2014 OneMedForum
in San Francisco on January 13 at 11:45 a.m. PST.
IlluminOss will provide an overview of its Photodynamic Bone
Stabilization System (PBSS), a minimally invasive technology that allows
for fracture fixation through patient specific intramedullary implants.
Dirk Kuyper will be available for one-on-one meetings during the
About IlluminOss Medical
IlluminOss Medical is a privately-held, commercial stage medical device
company focused on designing, developing and marketing orthopedic
fracture repair products that leverage its proprietary bone
stabilization technology, Photodynamic Bone Stabilization System (PBSS).
This minimally invasive technology allows for fracture fixation through
patient specific intramedullary implants. The PBSS System utilizes a
light-curable polymer, contained within an expandable balloon catheter,
to achieve bone stabilization. The revolutionary procedure is made
through a small percutaneous surgical approach providing patients and
clinicians with a fast, patient-customized, method of orthopedic bone
stabilization. The company currently markets its products in
international countries under a CE Mark for approved clinical
applications through both a direct sales force and distribution
networks. Founded in 2007, IlluminOss is headquartered in East
Providence, RI, and funded by Foundation Medical Partners, New Leaf
Venture Partners, Tekla Capital, Life Sciences Partners, SR One,
Longwood Fund, Excel Venture Management, Pappas Ventures, Mieza Capital
and Slater Technology. Learn more at www.illuminoss.com.
The IlluminOss products are Investigational Devices; limited by Federal
law to Investigational Use and are not approved for sale in the USA.
[ Back To NFVZone's Homepage ]